These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 11883016

  • 1. [Perinatal corticotherapy: updates].
    Hamon I, Hascoet JM.
    J Gynecol Obstet Biol Reprod (Paris); 2001 Oct; 30(6 Suppl):S50-3. PubMed ID: 11883016
    [Abstract] [Full Text] [Related]

  • 2. [Intrauterine stimulation for fetal respiratory system maturation; benefits and risks].
    Kinalski M, Sledziewski A, Kretowski A.
    Wiad Lek; 2000 Oct; 53(9-10):538-45. PubMed ID: 11148922
    [Abstract] [Full Text] [Related]

  • 3. [Corticosteroid for fetal lung maturation: indication and treatment protocols].
    Senat MV.
    J Gynecol Obstet Biol Reprod (Paris); 2002 Nov; 31(7 Suppl):5S105-13. PubMed ID: 12454632
    [Abstract] [Full Text] [Related]

  • 4. [Repetition of corticoid treatment for fetal lung maturation: clinical and experimental scientific data].
    Schmitz T, Goffinet F, Jarreau PH, Moriette G, Cabrol D.
    J Gynecol Obstet Biol Reprod (Paris); 2000 Sep; 29(5):458-68. PubMed ID: 11011275
    [Abstract] [Full Text] [Related]

  • 5. Antenatal steroid therapy: have we undervalued the risks?
    Cavalieri RL, Cohen WR.
    J Matern Fetal Neonatal Med; 2006 May; 19(5):265-9. PubMed ID: 16753765
    [Abstract] [Full Text] [Related]

  • 6. Effect of corticosteroids for fetal maturation on perinatal outcomes.
    NIH Consens Statement; 2006 May; 12(2):1-24. PubMed ID: 7728157
    [Abstract] [Full Text] [Related]

  • 7. [Induction of fetal lung maturation in the prevention of hyaline membrane disease: the connection with neonatal sepsis].
    Driul L, Furlan R, Macagno F, Pezzani I, Plaino L, Ianni A, Casarsa S, Zavarise D, Marchesoni D.
    Minerva Ginecol; 2003 Feb; 55(1):37-42. PubMed ID: 12598841
    [Abstract] [Full Text] [Related]

  • 8. [Perinatal glucocorticosteroid therapy: time for reconsideration].
    Groneck P.
    Z Geburtshilfe Neonatol; 2001 Feb; 205(6):231-5. PubMed ID: 11745009
    [Abstract] [Full Text] [Related]

  • 9. [Lung maturation therapy with glucocorticoids in threatened premature labor. Considerations of risk-benefit in evidence-based medicine].
    Sauerwald A, Rath W.
    Z Geburtshilfe Neonatol; 2000 Feb; 204(6):203-9. PubMed ID: 11199148
    [Abstract] [Full Text] [Related]

  • 10. Antenatal corticosteroid therapy in premature infants.
    Smrcek JM, Schwartau N, Kohl M, Berg C, Geipel A, Krapp M, Diedrich K, Ludwig M.
    Arch Gynecol Obstet; 2005 Jan; 271(1):26-32. PubMed ID: 15309401
    [Abstract] [Full Text] [Related]

  • 11. Repeated antenatal corticosteroid treatments. Do they reduce neonatal morbidity?
    Jazayeri A, Gavrila D, Sincich T.
    J Reprod Med; 2001 Sep; 46(9):788-90. PubMed ID: 11584477
    [Abstract] [Full Text] [Related]

  • 12. Neonatal effects and serum cortisol levels after multiple courses of maternal corticosteroids.
    Terrone DA, Smith LG, Wolf EJ, Uzbay LA, Sun S, Miller RC.
    Obstet Gynecol; 1997 Nov; 90(5):819-23. PubMed ID: 9351771
    [Abstract] [Full Text] [Related]

  • 13. Guideline for the use of antenatal corticosteroids for fetal maturation.
    Miracle X, Di Renzo GC, Stark A, Fanaroff A, Carbonell-Estrany X, Saling E, Coordinators Of World Associatin of Perinatal Medicine Prematurity Working Group.
    J Perinat Med; 2008 Nov; 36(3):191-6. PubMed ID: 18576926
    [Abstract] [Full Text] [Related]

  • 14. Incidence of respiratory disorders in neonates born between 34 and 36 weeks of gestation following exposure to antenatal corticosteroids between 24 and 34 weeks of gestation.
    Ventolini G, Neiger R, Mathews L, Adragna N, Belcastro M.
    Am J Perinatol; 2008 Feb; 25(2):79-83. PubMed ID: 18188800
    [Abstract] [Full Text] [Related]

  • 15. The effect of postnatal steroids on growth and development.
    Halliday HL.
    J Perinat Med; 2001 Feb; 29(4):281-5. PubMed ID: 11565195
    [Abstract] [Full Text] [Related]

  • 16. The effect of a prolonged time interval between antenatal corticosteroid administration and delivery on outcomes in preterm neonates: a cohort study.
    Ring AM, Garland JS, Stafeil BR, Carr MH, Peckman GS, Pircon RA.
    Am J Obstet Gynecol; 2007 May; 196(5):457.e1-6. PubMed ID: 17466700
    [Abstract] [Full Text] [Related]

  • 17. Single versus repeat courses of antenatal steroids to improve neonatal outcomes: risks and benefits.
    Bonanno C, Fuchs K, Wapner RJ.
    Obstet Gynecol Surv; 2007 Apr; 62(4):261-71. PubMed ID: 17371606
    [Abstract] [Full Text] [Related]

  • 18. [Repeat doses of prenatal corticosteroids for women at risk of preterm birth: a difficult consensus].
    Guilherme R, Renaud C, Dommergues M, Mitanchez D.
    J Gynecol Obstet Biol Reprod (Paris); 2009 Oct; 38(6):459-68. PubMed ID: 19473782
    [Abstract] [Full Text] [Related]

  • 19. Undesired effects of steroids during pregnancy.
    Mariotti V, Marconi AM, Pardi G.
    J Matern Fetal Neonatal Med; 2004 Nov; 16 Suppl 2():5-7. PubMed ID: 15590425
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of a single dose of antenatal corticosteroids on morbidity and mortality of preterm infants.
    Costa S, Zecca E, De Luca D, De Carolis MP, Romagnoli C.
    Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):154-7. PubMed ID: 16797825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.